Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • Ukraine
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
    • COVID-19
  • Features
    • How-to
    • Knowledge & Insights
    • Guest Contributions
  • Partners
    • Amsterdam
    • Rise by Techleap.nl
    • Fintech Files by AWS
    • Scaling-up in Europe
    • Blue Tulip Awards
    • Partner with us
    • Promoted content
  • Events
    • Technology Events in Europe
    • Submit your event
  • Jobs
  • About us
    • Partner with us
    • About
    • Team
    • Newsletter
  • Contact
  • Home
  • News
    • Ukraine
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
    • COVID-19
  • Features
    • How-to
    • Knowledge & Insights
    • Guest Contributions
  • Partners
    • Amsterdam
    • Rise by Techleap.nl
    • Fintech Files by AWS
    • Scaling-up in Europe
    • Blue Tulip Awards
    • Partner with us
    • Promoted content
  • Events
    • Technology Events in Europe
    • Submit your event
  • Jobs
  • About us
    • Partner with us
    • About
    • Team
    • Newsletter
  • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result
This article is produced in collaboration with our partner StartupAmsterdam

Amsterdam-based Castor raises €38.1M to help researchers globally conduct more effective clinical trials; here’s how

Editorial team by Editorial team
July 16, 2021
in (Crowd)funding, Amsterdam, Health & Medtech, News, Promoted content, Software & SaaS, Startups
Castor

Image credits: Castor

51
SHARES
LinkedInTwitterWhatsAppFacebook

Conducting a clinical trial is an arduous task! It involves hundreds and thousands of doctors, patients, researchers, and a substantial amount of data. 

The data generated in the trial is critical for ensuring the health and life of a patient, however, manual management might result in blunders leading to serious misinterpretation of data and negligence. 

- Partner content -
digital skills dutch workforce
Salesforce’s report on Dutch workforce’s digital skills
Has the Dutch workforce mastered all digital skills? Find out
Has the Dutch workforce mastered all digital skills? Find out Show Less
Read more

Realising this, the healthcare industry, as a whole, is moving towards technological cloud-based clinical trial software solutions for faster and more efficient clinical trials. 

Right now various companies are ruling the CTMS (Clinical Trial Management Software) market, and one such firm is Amsterdam-based Castor. Castor is on a mission to make every clinical trial faster and patient-focused. 

Raised €38M

Recently, the Dutch startup raised $45M (approx €38M) in funding in a Series B financing round led by Eight Roads Ventures and F-Prime Capital with participation from existing investors Two Sigma Ventures and Inkef Capital. This round brings the total funding to $65M (approx €55M). 

“Castor was created with the mission to help researchers globally conduct more effective clinical trials while improving the patient experience,” says Derk Arts in the press release “Prioritising the patient and site user experience is particularly important today when COVID-19 has fundamentally changed the nature of clinical trials.”

Based out of London, Eight Roads Ventures is a venture capital fund that backs game-changing technology and healthcare companies. The company has offices in China, India, Japan, and the UK. On the other hand, F-Prime Capital is a venture capital firm based out of Cambridge. The VC company invests in healthcare and technology.

Fund utilisation

Castor will use the funding to accelerate product development with a particular focus on scaling direct-to-patient trials globally. The company is planning to expand its operations, particularly in the US and APAC regions.

In an exclusive conversation with Silicon Canals, Derk Arts, M.D., CEO & Founder, Castor, says, “It definitely was not a question of if but rather when, though we have a deep understanding of the EU market it only makes up about 30 per cent of the clinical research market so we are all in on the US and eventually APAC. This series B round will fund product development, expansion into the Asia-Pacific region, hiring and doubling down on Castor’s U.S. footprint. Because without the US you’ll never win.”

On being asked what chunk of this funding round will be assigned to Amsterdam, Art says, “We’re a global remote-first company with over 150 Castorians in 20 countries. The core of our development team will continue to be grown from Amsterdam (ie the EMEA timezone). We expect about two-thirds of the funding to be spent on this side of the ocean.”

He adds, “Our Amsterdam team is 70 people strong – with another 80 remotely across the globe. As a remote-first company – we’re building and hiring for the best talent regardless of where they are located.” 

How does Castor’s solution work?

Founded in 2012 by Derk Arts, Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes. 

The company offers a self-service clinical research platform enabling the researcher to design studies and integrate data from any source in real-time. 

Interested patients can enroll themselves in trials and share their data online or via a mobile app. 

Supported over 7,500 studies

The company has supported over 7,500 studies in more than 90 countries. Castor’s academic studies cover a broad range of disease areas including diabetes, cardiovascular disease, central nervous system (CNS), rare diseases, infectious diseases, and oncology.   

In the past year, the company has worked with WHO and landed contracts with over 20 top-tier digital therapeutics companies, and signed its first top 5 pharmaceutical company.

Partnership with Lightship

Last month, Castor announced a partnership with Lightship to run direct-to-patient (hybrid) clinical trials at scale. 

Both the companies will work in close collaboration on clinical studies, providing a seamless experience for physicians, nurses, and study coordinators. 

Founded in 2018, Lightship is a provider of enterprise-level, direct-to-patient clinical research solutions for decentralised clinical trials.

For both Castor and Lightship, the patient experience comes before anything else. Together we’re improving access to clinical trials for a more diverse range of patients globally, and enhancing the process for patients and clinicians,” says Sam Eells, Co-Founder at Lightship. “This partnership further strengthens Lightship’s end-to-end service by helping to manage studies even more efficiently, with easy-to-use digital health technologies.”

 - Partner content -
How cybersecurity scaleup Intigriti conquered the world?
How cybersecurity scaleup Intigriti conquered the world?
Catch our interview with Paul Down, Head of Sales at Intigriti.
Catch our interview with Paul Down, Head of Sales at Intigriti. Show Less
Read more
Tags: amsterdamfeaturedfundingHealth-& MedtechNetherlandsstartups
Share4Tweet13SendShare20

Featured events

Current Month

may

28apr(apr 28)12:1331may(may 31)12:13FeaturedApplications for Techleap.nl’s Rise Batch 8 are open now

Techleap

Event Details

Are you an ambitious scaleup operating out of the Netherlands? Accelerate your growth with Techleap.nl’s Rise programme. Join their Batch #8!

Event Details

Are you an ambitious scaleup operating out of the Netherlands? Accelerate your growth with Techleap.nl’s Rise programme. Join their Batch #8!

Rise is an exclusive programme for serious tech players. In a trusted environment, scaleup founders share and discuss their growth challenges during tailor-made sessions with experienced entrepreneurs and scaling experts. Every quarter we select 10 companies to join the programme. It’s free, and we don’t seek equity. Check now if your company is eligible!

About Techleap

Techleap.nl’s programmes connect founders with scaling icons, industry experts and fellow tech entrepreneurs. It’s your chance to share challenges and hurdles with peers and established CEOs, and as a result, create favourable growth conditions for your business and overcome looming obstacles on your entrepreneurial path.

If you have any questions about the programme or the application process, please contact the Rise Batch Manager – Peter-Jan Kok at [email protected].

Apply here.

more

Time

April 28 (Thursday) 12:13 - May 31 (Tuesday) 12:13

Learn More

CalendarGoogleCal

june

Taets Art and Events ParkHemskade 16, 1506 PR Zaandam

16junAll Day17FeaturedTNW Conference

Event Details

Join TNW Conference in Amsterdam on June 16 & 17 to all you need to know about the latest market killers and breakout tech, connect with the industry’s who’s-who, and

Event Details

Join TNW Conference in Amsterdam on June 16 & 17 to all you need to know about the latest market killers and breakout tech, connect with the industry’s who’s-who, and turn your business meetings upside down on our ferris wheel… With endless networking opportunities, the world’s boldest voices, and unrivaled party vibes, this year’s TNW Conference will be off the charts!

Time

june 16 (Thursday) - 17 (Friday)

Location

Taets Art and Events Park

Hemskade 16, 1506 PR Zaandam

Learn More

CalendarGoogleCal

Partner content | Work with us

European Startups can expand to Asia through the South Korean Government’s K-Startup Grand Challenge

Running a small business? These 5 tips can create a domino effect of productivity across your entire company

Triller acquires Dutch DJ Sam Feldt’s Fangage to expand its platform for creators

Sweden’s Gimi partners with Dutch bank ABN AMRO to help young people manage and understand their finances

Calling all startups aiming to test their mobility innovations in the real world: Mobility Lab 2022 registration is now open

Silicon Canals | Jobs


Breaking news from Amsterdam | Partner

Founded by two ex-Googlers less than a year ago, Amsterdam’s GetEase raises €700K, launches new app

Amsterdam’s plant-based cheese startup Willicroft raises €2M led by Rockstart and PINC

Amsterdam-based Healthplus.ai raises funding from LUMO Labs to curb postsurgery infections; here’s how

Amsterdam-based Roetz drives away with €1.8M, plans to launch first circular e-bike this year

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2022 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • Ukraine
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
    • COVID-19
  • Features
    • How-to
    • Knowledge & Insights
    • Guest Contributions
  • Partners
    • Amsterdam
    • Rise by Techleap.nl
    • Fintech Files by AWS
    • Scaling-up in Europe
    • Blue Tulip Awards
    • Partner with us
    • Promoted content
  • Events
    • Technology Events in Europe
    • Submit your event
  • Jobs
  • About us
    • Partner with us
    • About
    • Team
    • Newsletter
  • Contact

Silicon Canals 2014-2022 | Website: Bright Idiots

Stay updated with the Silicon Canals daily and weekly newsletters.
We promise we won't spam you. You can choose to unsubscribe anytime.
Stay updated with the Silicon Canals daily and weekly newsletters.
We promise we won't spam you. You can choose to unsubscribe anytime.
Silicon Canals
Manage your privacy

To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Statistics

Marketing

Features
Always active

Always active
Manage options Manage services Manage vendors Read more about these purposes
Manage options
{title} {title} {title}
X
X